Advertisement
Demo

Catalyst Pharma sees net price of drug, once free, topping $300,000

Feb 12, 2019 , Reuters
Catalyst Pharmaceuticals Inc said on Monday that it expects its drug for a rare disease, which had long been available to patients for free, will cost more than $300,000 per year including rebates to insurers and other discounts.


Read the full story...


Trending healthcare news keywords at this moment

million research pain ebola digital diabetes finds cancer drug vaccine surgery tip heart study young aha news exercise care viewpoints state highlights proposes lawmakers approves medicare cases -- disease air lung kids severe workers toxic stroke measles adults blood pressure control women risk time sleep training affect brain takes public vaping americans doctors outbreak people linked treatment fda tb graphic patients meds half experts hospital mental hadlima children skyrizi